Objective: This experimental study examined the effect of erythropoietin (Epo) in a rat model and particularly in an adrenal ischemia-reperfusion (IR) protocol. The effect of that molecule was studied biochemically using blood mean testosterone levels (T).
Materials and methods: 40 rats of mean weight 247.7 g were used in the study. T levels were measured at 60 min (groups A and C) and at 120 min (groups B and D) of reperfusion. Erythropoietin was administered only in groups C and D.
Results: Erythropoietin administration non significantly increased the testosterone levels by 71.21%+44.19% (p=0.1080). Reperfusion time non-significantly decreased the testosterone levels by 65.17%+44.45% (p=0.0792). However, erythropoietin administration and reperfusion time together produced a non-significant combined effect in increasing the testosterone levels by 27.65%+27.21% (p= 0.3006).
Conclusions: Erythropoietin administration whether it interacted or not with reperfusion time has increasing non significant short-term effects on testosterone levels. Perhaps, a longer study time or a higher Epo dose, may reveal clearer and more significant effects.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. Tsompos C. Panoulis C. Toutouzas K. Triantafyllou A. Zografos G. & Papalois A. (2016). The effect of erythropoietin on calcium levels during hypoxia reoxygenation injury in rats. Geriatric care 2:5722:12-16.
2. Tsompos C. Panoulis C. Toutouzas K. Zografos G. & Papalois A. (2015). The effect of erythropoietin on albumins levels during hypoxia reoxygenation injury in rats. Research Journal of Pharmacology and Toxicology 1(3):42-45.
3. Tsompos C. Panoulis C. Toutouzas K. Triantafyllou A. Zografos G. & Papalois A. (2016). The Effect of Erythropoietin on Aspartate Aminotransferase Levels during Ischemia Reperfusion Injury in Rats. Electronic Journal of Biology 12(2): 161-167.
4. Tsompos C. Panoulis C. Toutouzas K. Triantafyllou A. Zografos G. & Papalois A. (2016). The acute trend of erythropoietin on platelet count during hypoxia reoxygenation injury in rats. Medical Channel Karachi 22 (1)7-13.
5. Tsompos C. Panoulis C. Toutouzas K. Zografos G. & Papalois A. (2016). The acute effect of erythropoietin on mean corpuscular hemoglobin concentration levels during hypoxia - reoxygenation injury in rats. J Med Soc 30 79-83.
6. Cakir E. Ozbek M. Sahin M. Cakal E. Gungunes A. Ginis Z. Demirci T. & Delibasi T. (2012). Heart type fatty acid binding protein response and subsequent development of atherosclerosis in insulin resistant polycystic ovary syndrome patients. J Ovarian Res. 18;5(1) 45.
7. Guven S. Karahan S.C. Bayram C. Ucar U. & Ozeren M. (2009). Elevated concentrations of serum ischaemia-modified albumin in PCOS a novel ischaemia marker of coronary artery disease. Reprod Biomed 19(4) 493-500.
8. Shaw L.J. Bairey Merz C.N. Azziz R. Stanczyk F.Z. Sopko G. Braunstein G.D. Kelsey S.F. Kip K.E. Cooper-Dehoff R.M. Johnson B.D. Vaccarino V. Reis S.E. Bittner V. Hodgson T.K. Rogers W. & Pepine CJ. (2008). Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart Lung and Blood Institute sponsored Women’s Ischemia Syndrome Evaluation. J Clin Endocrinol Metab. 93(4) 1276-84.
9. Kovalenko A.N. & Kostiuchenko V.G. (1987). Gonadal and gonadotropic function of late middle-aged men and women with sequelae of ischemic stroke. Zh Nevropatol Psikhiatr Im S S Korsakova 87(1) 29-33.
10. Klotz R.K. Müller-Holzner E. Fessler S. Reimer D.U. Zervomanolakis I. Seeber B. Mattle V. & Wildt L. (2010). Leydig-cell-tumor of the ovary that responded to GnRH-analogue administration - case report and review of the literature. Exp Clin Endocrinol Diabetes. 118(5) 291-7.
11. Stephen M.R. & Lindop G.B. (1998). A renin secreting ovarian steroid cell tumour associated with secondary polycythaemia. J Clin Pathol. 51(1) 75-7.